美国FDA_医疗器械体系法规QSR820中英文版-修订编选

上传人:黯然****空 文档编号:149414528 上传时间:2020-10-26 格式:PDF 页数:32 大小:289.50KB
返回 下载 相关 举报
美国FDA_医疗器械体系法规QSR820中英文版-修订编选_第1页
第1页 / 共32页
美国FDA_医疗器械体系法规QSR820中英文版-修订编选_第2页
第2页 / 共32页
亲,该文档总共32页,到这儿已超出免费预览范围,如果喜欢就下载吧!
资源描述

《美国FDA_医疗器械体系法规QSR820中英文版-修订编选》由会员分享,可在线阅读,更多相关《美国FDA_医疗器械体系法规QSR820中英文版-修订编选(32页珍藏版)》请在金锄头文库上搜索。

1、美国美国 FDA 医疗器械体系法规医疗器械体系法规 QSR820 中文版中文版 Part 820质量体系法规目录 Subpart A- 总则 820.1 范围 820.3 定义 820.5 质量体系 Subpart B 质量体系要求 820.20 管理职责 820.22 质量审核 820.25 人员 Subpart C- 设计控制 820.30 设计控制 Subpart D- 文件控制 820.40 文件控制 Subpart E- 采购控制 820.50 采购控制 Subpart F- 标识与可追溯性 820.60 标识 820.65 可追溯性 Subpart G - 生产和过程控制 820.

2、70 生产和过程控制 820.72 检验、测量和试验设备 820.75 过程确认 Subpart H - 验收活动: 820.80 进货、过程和成品器械检验 820.86 检验状态 Subpart I 不合格品 820.90 不合格品 Subpart J - 纠正和预防措施 820.100 纠正和预防措施 Subpart K 标识和包装控制 820.120 设备标签 820.130 设备包装 Subpart L 搬运/储存/分销和安装 820.140 搬运 820.150 贮存 820.160 分销 820.170 安装 Subpart L 记录 820.180 记录的通用要求 820.181

3、 设备主要记录 820.184 设备历史记录 820.186 质量体系记录 820.198 投诉文件 Subpart M 服务 820.200 服务 Subpart N 统计技术 820.250 统计技术 Subpart A总则 Subpart A-General Provisions Sec.820.1 范围 Sec. 820.1 Scope. (a) 适用性Applicability。 (1) 本质量体系法规阐明了当前良好制造法规 Current good manufacturing practice (CGMP)的要求。本标准适用于所有预期用于人类的成品器械的设计、制造、包装、标识、 储

4、存、安装和服务中所使用的管理方法、设施和控制。本标准的目的是保证成品器械的安全 性和有效性,并符合联邦食品、药品和化妆品法案 Federal Food, Drag and Cosmetic Act (the act)。 本法规适用于所有的医疗器械成品制造商。 如果制造商仅从事本部分有要求服 从的某些过程而未从事其它过程,则只需符合其实施的过程的要求。对于类设备,设计控 制仅适用于 Sec.820.30(a)(2)中列出的设备。本法规不适用于成品器械的部件或零件 制造商, 但鼓励这类制造商把本法规的适当规定作为指南来使用。 人血和血液成分制造商不 受本部分法规的限制,但应遵循本章 606 部分法

5、规的要求。 Current good manufacturing practice (CGMP) requirements are set forth in this quality system regulation. The requirements in this part govern the methods used in, and the facilities and controls used for, the design, manufacture, packaging, labeling, storage, installation, and servicing of all

6、 finished devices intended for human use. The requirements in this part are intended to ensure that finished devices will be safe and effective and otherwise in compliance with the Federal Food, Drug, and Cosmetic Act (the act). This part establishes basic requirements applicable to manufacturers of

7、 finished medical devices. If a manufacturer engages in only some operations subject to the requirements in this part, and not in others, that manufacturer need only comply with those requirements applicable to the operations in which it is engaged. With respect to class I devices, design controls a

8、pply only to those devices listed in 820.30(a) This regulation does not apply to manufacturers of components or parts of finished devices, but such manufacturers are encouraged to use appropriate provisions of this regulation as guidance. Manufacturers of human blood and blood components are not sub

9、ject to this part, but are subject to part 606 of this chapter. Manufacturers of human cells, tissues, and cellular and tissue-based products (HCT/Ps), as defined in 1271. .3(d) of this chapter, that are medical devices (subject to premarket review or notification, or exempt from notification, under

10、 an application submitted under the device provisions of the act or under a biological product license application under section 351 of the Public Health Service Act) are subject to this part and are also subject to the donor-eligibility procedures set forth in part 1271 subpart C of this chapter an

11、d applicable current good tissue practice procedures in part 1271 subpart D of this chapter. In the event of a conflict between applicable regulations in part 1271 and in other parts of this chapter, the regulation specifically applicable to the device in question shall supersede the more general. (

12、2) 本部分的规定适用于本部分定义的预期用于人体的所有成品器械,不论其在美国(包 含:美国任何州或领土,哥伦比亚特区,波多黎各联邦)本土制造还是进口,提供进口的产品。 (2) The provisions of this part shall be applicable to any finished device as defined in this part, intended for human use, that is manufactured, imported, or offered for import in any State or Territory of the Unite

13、d States, the District of Columbia, or the Commonwealth of Puerto Rico. (3) 在本法规中“适用时”(where appropriate)出现过多次。当要求根据“where appropriate”被认为是合格时,其要求应被认为是“适用的”(appropriate),除非组织能提 供文件证明其理由。 如果不执行预期结果会导致产品不符合其特定的要求, 或组织不需要执 行任何必要的纠正措施,那么要求就是适用的(appropriate)。 (3) In this regulation the term where appropr

14、iate is used several times. When a requirement is qualified by where appropriate, it is deemed to be appropriate unless the manufacturer can document justification otherwise. A requirement is appropriate if non-implementation could reasonably be expected to result in the product not meeting its spec

15、ified requirements or the manufacturer not being able to carry out any necessary corrective action. (b) 限制。除非特别规定,则本部分质量体系法规是本章其它部分法规的补充要求。在不 能符合所有适用的法规,包括本章此部分和其它部分的情况,特别是对讨论中的设备,此法 规应取代其它通用要求。 (b) The quality system regulation in this part supplements regulations in other parts of this chapter exc

16、ept where explicitly stated otherwise. In the event of a conflict between applicable regulations in this part and in other parts of this chapter, the regulations specifically applicable to the device in question shall supersede any other generally applicable requirements. (c) 权限。 PART820 是在 (21U.S.C.法令 351、 352、 360、 360c、 360d、 360e、 360h、 360i、 360j、 360l、 370、

展开阅读全文
相关资源
相关搜索

当前位置:首页 > 办公文档 > PPT模板库 > 总结/计划/报告

电脑版 |金锄头文库版权所有
经营许可证:蜀ICP备13022795号 | 川公网安备 51140202000112号